Your session is about to expire
← Back to Search
Lifestyle Intervention for Obesity
Study Summary
This trial will use 4 evidence-based components to help taxi/FHV drivers reduce weight, improve health, and create a scalable & effective lifestyle intervention.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am overweight or obese based on my BMI.I am at least 21 years old.I speak English, French, Bengali, or Spanish.I have a chronic disease like cancer, kidney, or liver disease.I am 18 years or older and part of the COMIDA family study.I have a chronic disease like cancer or kidney disease that may limit my diet.I have a chronic disease like cancer or kidney disease, but I can still join if I have high blood pressure or diabetes.I prefer to communicate in Spanish.A member of my household is already in the SANOS RCT study.I have a chronic disease like cancer, kidney, or liver disease but may still have diabetes, lactose intolerance, or high blood pressure.I am overweight or obese based on my BMI.I have a chronic disease but it's not diabetes, lactose intolerance, or high blood pressure.I prefer to communicate in Spanish.I am 18 years or older.I have a child under 18 living with me.I am 18 years old or older.I am 21 years old or older.I am a full-time taxi or FHV driver, working at least 35 hours a week.I am overweight or obese based on my BMI.A family member is already participating in the COMIDA study.I prefer to communicate in Spanish.I am overweight or obese according to my BMI.I prefer to communicate in Spanish.I either don't have a text-capable phone or I'm unwilling to receive texts.I am 18 years old or older.
- Group 1: SANOS
- Group 2: ROADmAP schema
- Group 3: Consumo de Opciones Mas Ideales De Alimento (COMIDA)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any remaining spots available for participants in this research?
"Affirmative. According to the clinical trials database, this medical research is currently accepting applicants. Initially posted on December 22nd 2022 and last updated March 20th 2023, it requires 1067 participants from a single site."
What is the population size for this research endeavor?
"Affirmative. According to clinicaltrials.gov, this research is actively enrolling participants starting from December 22nd 2022 and was recently updated on March 20th 20323. The team are hoping to recruit 1067 subjects across a single medical centre."
What risks might patients face if they adhere to the ROADmAP schema?
"ROADmAP schema has been assessed as having a level of safety that corresponds to 2 on our 3-tier scale, given its Phase 2 status. This implies the presence of evidence corroborating its security but none vouching for its effectiveness."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger